Sylvie C. Mader
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
A Chemical-Genetic Interaction Matrix Reveals Drug Mechanism and Genetic Architecture.
Journal: bioRxiv : the preprint server for biology
Published: February 09, 2026
A ZNF-nanobody fusion reveals SUMOylation-dependent changes in p53 protein localization.
Journal: iScience
Published: November 05, 2025
CDADC1 is a vertebrate-specific dCTP deaminase that metabolizes gemcitabine and decitabine to prevent cellular toxicity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 12, 2025
A short SUMOylation tag modulates transcription factor activity.
Journal: The Journal of biological chemistry
Published: May 17, 2025
IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics Competition.
Journal: Cancers
Published: August 26, 2024
Design, synthesis and antiproliferative activity of raloxifene/histone deacetylase inhibitor hybrids in breast cancer.
Journal: European journal of medicinal chemistry
Published: September 27, 2023
The AF-2 cofactor binding region is key for the selective SUMOylation of estrogen receptor alpha by antiestrogens.
Journal: The Journal of biological chemistry
Published: October 17, 2022
Estrogens desensitize MCF-7 breast cancer cells to apelin-induced autophagy and enhanced growth under estrogen starvation: a possible implication in endocrine resistance.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: September 29, 2022
CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3.
Journal: Cancers
Published: September 26, 2022
Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis.
Journal: Cells
Published: August 16, 2021
Dual-function antiandrogen/HDACi hybrids based on enzalutamide and entinostat.
Journal: Bioorganic & medicinal chemistry letters
Published: August 01, 2021
Last Updated: 09/26/2026